0001844862--12-31 2024 Q2 false P3Y 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputPriceVolatilityMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputExpectedTermMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputExercisePriceMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001844862 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001844862 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001844862 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001844862 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001844862 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001844862 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001844862 us-gaap:RetainedEarningsMember 2024-06-30 0001844862 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001844862 us-gaap:RetainedEarningsMember 2024-03-31 0001844862 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001844862 2024-03-31 0001844862 us-gaap:RetainedEarningsMember 2023-12-31 0001844862 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001844862 us-gaap:RetainedEarningsMember 2023-06-30 0001844862 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001844862 us-gaap:RetainedEarningsMember 2023-03-31 0001844862 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001844862 2023-03-31 0001844862 us-gaap:RetainedEarningsMember 2022-12-31 0001844862 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001844862 us-gaap:CommonStockMember 2024-06-30 0001844862 us-gaap:CommonStockMember 2024-03-31 0001844862 us-gaap:CommonStockMember 2023-12-31 0001844862 us-gaap:CommonStockMember 2023-06-30 0001844862 us-gaap:CommonStockMember 2023-03-31 0001844862 us-gaap:CommonStockMember 2022-12-31 0001844862 us-gaap:EmployeeStockOptionMember 2024-06-30 0001844862 us-gaap:EmployeeStockOptionMember 2024-03-31 0001844862 us-gaap:EmployeeStockOptionMember 2023-12-31 0001844862 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2024-06-30 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2024-04-01 2024-06-30 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2024-01-01 2024-06-30 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2023-04-01 2023-06-30 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0001844862 us-gaap:LeaseholdImprovementsMember 2024-06-30 0001844862 us-gaap:EquipmentMember 2024-06-30 0001844862 us-gaap:ConstructionInProgressMember 2024-06-30 0001844862 sldp:LaboratoryEquipmentMember 2024-06-30 0001844862 sldp:FurnitureAndComputerEquipmentMember 2024-06-30 0001844862 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001844862 us-gaap:EquipmentMember 2023-12-31 0001844862 us-gaap:ConstructionInProgressMember 2023-12-31 0001844862 sldp:LaboratoryEquipmentMember 2023-12-31 0001844862 sldp:FurnitureAndComputerEquipmentMember 2023-12-31 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2024-06-30 0001844862 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001844862 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001844862 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001844862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001844862 2021-09-01 0001844862 srt:MinimumMember 2024-06-30 0001844862 srt:MaximumMember 2024-06-30 0001844862 us-gaap:TrademarksMember 2024-06-30 0001844862 sldp:TrademarksPendingMember 2024-06-30 0001844862 sldp:PatentsPendingMember 2024-06-30 0001844862 us-gaap:TrademarksMember 2023-12-31 0001844862 sldp:TrademarksPendingMember 2023-12-31 0001844862 sldp:PatentsPendingMember 2023-12-31 0001844862 us-gaap:PatentsMember 2024-06-30 0001844862 us-gaap:LicensingAgreementsMember 2024-06-30 0001844862 us-gaap:PatentsMember 2023-12-31 0001844862 us-gaap:LicensingAgreementsMember 2023-12-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001844862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001844862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-12-31 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-04-01 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-04-01 2024-06-30 0001844862 us-gaap:FairValueMeasurementsRecurringMember 2024-04-01 2024-06-30 0001844862 us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001844862 us-gaap:PropertyPlantAndEquipmentMember 2024-04-01 2024-06-30 0001844862 us-gaap:PropertyPlantAndEquipmentMember 2024-01-01 2024-06-30 0001844862 us-gaap:PropertyPlantAndEquipmentMember 2023-04-01 2023-06-30 0001844862 us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-06-30 0001844862 sldp:BmwOfNorthAmericaLlcMember us-gaap:RelatedPartyMember 2023-12-31 0001844862 sldp:Sp2IncreasedScaleElectrolyteProductionMember 2024-06-30 0001844862 sldp:Sp1CapitalProjectsMember 2024-06-30 0001844862 sldp:Sp2IncreasedScaleElectrolyteProductionMember 2023-12-31 0001844862 sldp:Sp1CapitalProjectsMember 2023-12-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001844862 sldp:PublicWarrantsMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember 2024-06-30 0001844862 sldp:PublicWarrantsMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember 2023-12-31 0001844862 us-gaap:WarrantMember 2024-06-30 0001844862 2023-06-30 0001844862 2022-12-31 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-06-30 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2024-06-30 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-06-30 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-06-30 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2024-06-30 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-06-30 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2023-12-31 0001844862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2023-12-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2023-12-31 0001844862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2023-12-31 0001844862 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001844862 sldp:EquityIncentive2021PlanMember 2024-01-01 2024-06-30 0001844862 sldp:EquityIncentive2014And2021PlanMember 2024-01-01 2024-06-30 0001844862 sldp:EmployeeStockPurchasePlan2021Member 2024-01-01 2024-06-30 0001844862 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001844862 sldp:EquityIncentive2021PlanMember 2023-01-01 2023-06-30 0001844862 sldp:EquityIncentive2014And2021PlanMember 2023-01-01 2023-06-30 0001844862 sldp:EmployeeStockPurchasePlan2021Member 2023-01-01 2023-06-30 0001844862 sldp:ContingentlyIssuableCommonStockMember 2023-01-01 2023-06-30 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0001844862 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0001844862 sldp:EmployeeStockPurchasePlanMember 2024-04-01 2024-06-30 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-06-30 0001844862 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001844862 sldp:EmployeeStockPurchasePlanMember 2024-01-01 2024-06-30 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0001844862 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001844862 sldp:EmployeeStockPurchasePlanMember 2023-04-01 2023-06-30 0001844862 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001844862 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001844862 sldp:EmployeeStockPurchasePlanMember 2023-01-01 2023-06-30 0001844862 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001844862 2023-01-01 2023-03-31 0001844862 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001844862 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001844862 2024-01-01 2024-03-31 0001844862 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001844862 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001844862 2024-01-23 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001844862 sldp:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-03-31 0001844862 sldp:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-03-31 0001844862 2024-04-01 2024-06-30 0001844862 2023-04-01 2023-06-30 0001844862 2023-12-31 0001844862 2024-06-30 0001844862 2023-01-01 2023-06-30 0001844862 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001844862 sldp:WarrantsMember 2024-01-01 2024-06-30 0001844862 2024-08-05 0001844862 2024-01-01 2024-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure sldp:Y

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 001-40284

SOLID POWER, INC.

(Exact name of registrant as specified in its charter)

​

Delaware |  | 86-1888095
(State or other jurisdiction of |  | (I.R.S. Employer
incorporation or organization) |  | Identification No.)
486 S. Pierce Ave., Suite E |  |
Louisville, Colorado |  | 80027
(Address of principal executive offices) |  | (Zip Code)

​

(303) 219-0720

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading symbol(s) |  | Name of each exchange on which registered
Common stock, par value $0.0001 per share |  | SLDP |  | The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 |  | SLDPW |  | The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ | ​ | Accelerated filer ☐ | ​ | Non-accelerated filer ☒ | ​ | Smaller reporting company ☒
|  |  | ​ |  | ​ | Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

178,962,858 shares of common stock were issued and outstanding as of August 5, 2024.

​

​

​

​

Table of Contents

SOLID POWER, INC.

FORM 10-Q

Table of Contents

| ​ | ​
| ​ | ​
PART I. FINANCIAL INFORMATION | ​
Item 1. | Financial Statements | 5
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 17
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 21
Item 4. | Controls and Procedures | 21
​ | ​ | ​
PART II. OTHER INFORMATION | ​
Item 1. | Legal Proceedings | 22
Item 1A. | Risk Factors | 22
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 22
Item 6. | Exhibits | 23
​ | ​ | ​
Signatures | ​ | 24

​

​

​

​

​

1

Table of Contents

GLOSSARY OF DEFINED TERMS

Term | ​ | Definition
2014 Plan | ​ | Solid Power, Inc. 2014 Equity Incentive Plan
2021 Plan | ​ | Solid Power, Inc. 2021 Equity Incentive Plan
2023 Form 10-K | ​ | Our Annual Report on Form 10-K for the year ended December 31, 2023
Ah | ​ | Ampere hour
BMW | ​ | BMW of North America LLC
Board | ​ | The Board of Directors of Solid Power, Inc.
Electrolyte Supply Agreement | ​ | Electrolyte Supply Agreement, dated January 10, 2024, between Solid Power Operating, Inc. and SK On
ESPP | ​ | Solid Power, Inc. 2021 Employee Stock Purchase Plan
EV | ​ | Battery electric vehicle
EV cells | ​ | Prototype cell formats between 60 and 100 Ah
Exchange Act | ​ | Securities Exchange Act of 1934, as amended
GAAP | ​ | U.S. generally accepted accounting principles
JDA | ​ | Joint development agreement
Line Installation Agreement | ​ | Line Installation Agreement, dated January 10, 2024, among Solid Power Korea Co., Ltd., SK On, and, for the limited purposes of Section 12.16 of the Line Installation Agreement, Solid Power
Notes | ​ | Notes to the Condensed Consolidated Financial Statements (Unaudited) in this Report
OEM | ​ | Automotive original equipment manufacturers
Private Placement Warrants | ​ | Warrants sold in a private placement as part of our initial public offering or acquired through a conversion of a working capital loan
Public Warrants | ​ | Our publicly-traded warrants
R&D License Agreement | ​ | Research and Development Technology License Agreement, dated January 10, 2024, between Solid Power Operating, Inc. and SK On
Report | ​ | This Quarterly Report on Form 10-Q
RSU | ​ | Restricted stock unit
SEC | ​ | Securities and Exchange Commission
SK On | ​ | SK On Co., Ltd.
SK On Agreements | ​ | Electrolyte Supply Agreement, Line Installation Agreement, and R&D License Agreement, collectively
Solid Power / the Company / we / us / our | ​ | Solid Power, Inc., a Delaware corporation (f/k/a Decarbonization Plus Acquisition Corporation III)
SP1 | ​ | Our Louisville, Colorado facility, which we primarily use for cell production, research and development, and quality control
SP2 | ​ | Our Thornton, Colorado facility, which we primarily use for pilot production of electrolyte, research and development, quality control, and general office space
Warrants | ​ | Private Placement Warrants and Public Warrants

​

​

2

Table of Contents

Cautionary Note Regarding Forward-Looking Statements

This Report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. We have based these forward-looking statements on our current expectations and projections about future events. All statements, other than statements of present or historical fact included in this Report, regarding our future financial performance and our strategy, expansion plans, market opportunity, future operations, future operating results, estimated revenues or losses, projected costs, prospects, plans, and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “continue,” “project,” or the negative of such terms or other similar expressions. These forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Report. We caution you that the forward-looking statements contained herein are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond our control.

In addition, we caution you that the forward-looking statements regarding the Company contained in this Report are subject to the following factors:

| ● | risks relating to the uncertainty of the success of our research and development efforts, including our ability to achieve the technological objectives or results that our partners require, and our ability to commercialize our technology in advance of competing technologies;

| ● | rollout of our business plan and the timing of expected business milestones;

| ● | risks relating to the non-exclusive nature of our OEM and other partner relationships and our ability to manage these business relationships;

| ● | our ability to negotiate and execute commercial agreements with our partners on commercially reasonable terms;

| ● | our ability to protect and maintain our intellectual property, including in jurisdictions outside of the United States;

| ● | broad market adoption of EVs and other technologies where we are able to deploy our technology, if developed successfully;

| ● | our success attracting and retaining our executive officers, key employees, and other qualified personnel;

| ● | changes in applicable laws or regulations;

| ● | risks relating to our information technology infrastructure and data security breaches;

| ● | risks relating to our status as a research and development stage company with a history of financial losses with an expectation of incurring significant expenses and continuing losses for the foreseeable future;

| ● | our ability to secure government contracts and grants and the availability of government subsidies and economic incentives;

| ● | delays in the construction and operation of additional facilities;

| ● | risks relating to other economic, business, or competitive factors in the United States and other jurisdictions, including supply chain interruptions and changes in market conditions, and our ability to manage these risks and uncertainties; and

| ● | those factors discussed in “Part I, Item 1A. Risk Factors” in our 2023 Form 10-K, as such description may be updated or amended in future filings we make with the SEC.

3

Table of Contents

We caution you that the foregoing list does not contain all of the risks or uncertainties that could affect the Company.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, operating results, financial condition and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors, including those described in “Part I, Item 1A. Risk Factors” in our 2023 Form 10-K, as such description may be updated or amended in future filings we make with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Report to reflect events or circumstances after the date of this Report or to reflect new information or the occurrence of unanticipated events, except as required by law. You should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

TRADEMARKS

Our logo and trademark appearing in this Report and the documents incorporated by reference herein are our property. This document and the documents incorporated by reference herein contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Report may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.

MARKET AND INDUSTRY DATA

We obtained the industry and market data used throughout this Report or any documents incorporated herein by reference from our own internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information, and research, surveys, and studies conducted by third parties. Internal estimates are derived from publicly available information released by industry analysts and third-party sources, our internal research, and our industry experience and are based on assumptions made by us based on such data and our knowledge of our industry and market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this Report or any documents incorporated herein by reference is reliable and based on reasonable assumptions, such data involve material risks and other uncertainties and is subject to change based on various factors, including those discussed in the section entitled “Risk Factors.” These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us.

INFORMATION ABOUT SOLID POWER

We use our website (www.solidpowerbattery.com) and various social media channels (e.g., Solid Power, Inc. on LinkedIn) as a means of disclosing information about Solid Power and our products to our customers, investors, and the public. The information posted on our website and social media channels is not incorporated by reference in this Report or in any other report or document we file with the SEC. Further, references to our website URLs are intended to be inactive textual references only. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Solid Power when you enroll your e-mail address by visiting the “Investor Email Alerts” section of our website at https://ir.solidpowerbattery.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act are filed with the SEC. These reports and other information we file with the SEC are available free of charge at https://www.solidpowerbattery.com/investor-relations/financials/sec-filings when such reports are available on the SEC’s website.

​

​

4

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Solid Power, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value and number of shares)

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2024 | ​ | ​ | ​ | ​
​ |  | (Unaudited) |  | December 31, 2023 | ​
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current Assets |  | ​ |  |  | ​ |  | ​
Cash and cash equivalents | ​ | $ | 30,638 | ​ | $ | 34,537 | ​
Marketable securities | ​ | ​ | 109,882 | ​ | ​ | 141,505 | ​
Contract receivables | ​ |  | 7,766 | ​ |  | 1,553 | ​
Contract receivables from related parties | ​ | ​ | 4,581 | ​ | ​ | — | ​
Prepaid expenses and other current assets | ​ |  | 7,959 | ​ |  | 5,523 | ​
Total current assets | ​ |  | 160,826 | ​ |  | 183,118 | ​
Long-Term Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​
Property, plant and equipment, net | ​ |  | 99,727 | ​ |  | 99,156 | ​
Right-of-use operating lease assets, net | ​ | ​ | 6,852 | ​ | ​ | 7,154 | ​
Right-of-use finance lease assets, net | ​ | ​ | 972 | ​ | ​ | 1,088 | ​
Investments | ​ | ​ | 218,313 | ​ | ​ | 239,566 | ​
Intangible assets, net | ​ |  | 1,912 | ​ |  | 1,650 | ​
Other assets | ​ | ​ | 4,025 | ​ | ​ | 1,060 | ​
Total long-term assets | ​ | ​ | 331,801 | ​ | ​ | 349,674 | ​
Total assets | ​ | $ | 492,627 | ​ | $ | 532,792 | ​
Liabilities and Stockholders’ Equity | ​ |  | ​ | ​ |  | ​ | ​
Current Liabilities | ​ |  | ​ | ​ |  | ​ | ​
Accounts payable and other accrued liabilities | ​ | ​ | 7,285 | ​ | ​ | 6,455 | ​
Deferred revenue | ​ |  | 10,075 | ​ |  | 1 | ​
Deferred revenue from related parties | ​ | ​ | — | ​ | ​ | 828 | ​
Accrued compensation | ​ |  | 4,559 | ​ |  | 7,590 | ​
Operating lease liabilities | ​ | ​ | 668 | ​ | ​ | 626 | ​
Finance lease liabilities | ​ | ​ | 362 | ​ | ​ | 379 | ​
Total current liabilities | ​ |  | 22,949 | ​ |  | 15,879 | ​
Long-Term Liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Warrant liabilities | ​ | ​ | 4,025 | ​ | ​ | 4,227 | ​
Operating lease liabilities | ​ | ​ | 7,649 | ​ | ​ | 7,996 | ​
Finance lease liabilities | ​ |  | 381 | ​ |  | 552 | ​
Other liabilities | ​ |  | 845 | ​ |  | 803 | ​
Total long-term liabilities | ​ | ​ | 12,900 | ​ | ​ | 13,578 | ​
Total liabilities | ​ | ​ | 35,849 | ​ | ​ | 29,457 | ​
Stockholders’ Equity | ​ |  |  | ​ |  |  | ​
Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 178,640,611 and 179,010,884 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively | ​ |  | 18 | ​ |  | 18 | ​
Additional paid-in capital | ​ |  | 586,029 | ​ | ​ | 588,515 | ​
Accumulated deficit | ​ |  | (128,120) | ​ |  | (84,639) | ​
Accumulated other comprehensive loss | ​ | ​ | (1,149) | ​ | ​ | (559) | ​
Total stockholders’ equity | ​ |  | 456,778 | ​ |  | 503,335 | ​
Total liabilities and stockholders’ equity | ​ | $ | 492,627 | ​ | $ | 532,792 | ​

​

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

​

​

5

Table of Contents

Solid Power, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except number of shares and per share amounts)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended June 30, | ​ | Six Months Ended June 30, | ​
​ | ​ | 2024 |  | 2023 | ​ | 2024 |  | 2023 | ​
Revenue | ​ | $ | 5,075 | ​ | $ | 4,906 | ​ | $ | 11,028 | ​ | $ | 8,698 | ​
Operating Expenses | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
Direct costs | ​ | ​ | 5,437 | ​ | ​ | 6,897 | ​ | ​ | 9,727 | ​ | ​ | 13,171 | ​
Research and development | ​ | ​ | 18,526 | ​ |  | 14,508 | ​ | ​ | 37,400 | ​ |  | 26,156 | ​
Selling, general and administrative | ​ | ​ | 8,049 | ​ |  | 5,673 | ​ | ​ | 16,619 | ​ |  | 12,862 | ​
Total operating expenses | ​ | ​ | 32,012 | ​ |  | 27,078 | ​ | ​ | 63,746 | ​ |  | 52,189 | ​
Operating Loss | ​ | ​ | (26,937) | ​ |  | (22,172) | ​ | ​ | (52,718) | ​ |  | (43,491) | ​
Nonoperating Income and Expense | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
Interest income | ​ | ​ | 4,520 | ​ | ​ | 4,993 | ​ | ​ | 9,637 | ​ | ​ | 9,827 | ​
Change in fair value of warrant liabilities | ​ | ​ | 703 | ​ | ​ | 4,987 | ​ | ​ | 202 | ​ | ​ | 2,325 | ​
Interest expense | ​ | ​ | (49) | ​ |  | (13) | ​ | ​ | (91) | ​ | ​ | (26) | ​
Total nonoperating income and expense | ​ | ​ | 5,174 | ​ |  | 9,967 | ​ | ​ | 9,748 | ​ |  | 12,126 | ​
Pretax Loss | ​ | $ | (21,763) | ​ | $ | (12,205) | ​ | $ | (42,970) | ​ | $ | (31,365) | ​
Income tax expense | ​ | ​ | 511 | ​ | ​ | — | ​ | ​ | 511 | ​ | ​ | — | ​
Net Loss Attributable to Common Stockholders | ​ | $ | (22,274) | ​ | $ | (12,205) | ​ | $ | (43,481) | ​ | $ | (31,365) | ​
Other Comprehensive Income (Loss) | ​ | ​ | (11) | ​ | ​ | 1,098 | ​ | ​ | (590) | ​ | ​ | (213) | ​
Comprehensive Loss Attributable to Common Stockholders | ​ | $ | (22,285) | ​ | $ | (11,107) | ​ | $ | (44,071) | ​ | $ | (31,578) | ​
Basic and diluted loss per share | ​ | $ | (0.13) | ​ | $ | (0.07) | ​ | $ | (0.24) | ​ | $ | (0.18) | ​
Weighted average shares outstanding – basic and diluted | ​ | ​ | 177,588,035 | ​ | ​ | 178,063,573 | ​ | ​ | 179,186,027 | ​ | ​ | 177,502,037 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

​

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

​

6

Table of Contents

Solid Power, Inc.

Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)

(in thousands, except number of shares)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Accumulated | ​ | Accumulated Other | ​ | Total Stockholders’
​ |  | Shares |  | Amount |  | paid-in capital |  | deficit |  | Comprehensive Loss |  | Equity
Balance as of December 31, 2023 | ​ | ​ | 179,010,884 | ​ | $ | 18 | ​ | $ | 588,515 | ​ | $ | (84,639) | ​ | $ | (559) | ​ | $ | 503,335
Net loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (21,207) | ​ | ​ | — | ​ | ​ | (21,207)
Withholding of employee taxes related to stock-based compensation | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (169) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (169)
Shares of common stock issued for vested RSUs | ​ | ​ | 161,995 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock options exercised | ​ | ​ | 2,360,316 | ​ | ​ | — | ​ | ​ | 97 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 97
Repurchase and retirement of shares of common stock | ​ | ​ | (3,183,638) | ​ | ​ | — | ​ | ​ | (4,963) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (4,963)
Stock-based compensation expense | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2,863 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2,863
Unrealized loss on marketable securities | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (579) | ​ | ​ | (579)
Balance as of March 31, 2024 | ​ | ​ | 178,349,557 | ​ | $ | 18 | ​ | $ | 586,343 | ​ | $ | (105,846) | ​ | $ | (1,138) | ​ | $ | 479,377
Net loss | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | (22,274) | ​ | ​ | — | ​ |  | (22,274)
Shares of common stock issued under the ESPP | ​ | ​ | 187,614 | ​ | ​ | — | ​ | ​ | 238 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 238
Withholding of employee taxes related to stock-based compensation | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | (310) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (310)
Shares of common stock issued for vested RSUs | ​ | ​ | 689,221 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock options exercised | ​ |  | 1,230,581 | ​ |  | — | ​ | ​ | 100 | ​ |  | — | ​ | ​ | — | ​ |  | 100
Repurchase and retirement of shares of common stock | ​ | ​ | (1,816,362) | ​ | ​ | — | ​ | ​ | (3,393) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (3,393)
Stock-based compensation expense | ​ |  | — | ​ |  | — | ​ | ​ | 3,051 | ​ |  | — | ​ | ​ | — | ​ |  | 3,051
Unrealized loss on marketable securities | ​ | ​ | — | ​ |  | — | ​ | ​ | — | ​ |  | — | ​ | ​ | (11) | ​ | ​ | (11)
Balance as of June 30, 2024 | ​ | ​ | 178,640,611 | ​ | $ | 18 | ​ | $ | 586,029 | ​ | $ | (128,120) | ​ | $ | (1,149) | ​ | $ | 456,778

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Accumulated | ​ | Accumulated Other | ​ | Total Stockholders’
​ |  | Shares |  | Amount |  | paid-in capital |  | deficit |  | Comprehensive Loss |  | Equity
Balance as of December 31, 2022 | ​ | ​ | 176,007,184 | ​ | $ | 18 | ​ | $ | 577,603 | ​ | $ | (19,090) | ​ | $ | (3,159) | ​ | $ | 555,372
Net loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (19,158) | ​ | ​ | — | ​ | ​ | (19,158)
Stock options exercised | ​ | ​ | 1,679,954 | ​ | ​ | — | ​ | ​ | 150 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 150
Stock-based compensation expense | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2,222 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2,222
Unrealized gain on marketable securities | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 885 | ​ | ​ | 885
Balance as of March 31, 2023 | ​ | ​ | 177,687,138 | ​ | $ | 18 | ​ | $ | 579,975 | ​ | $ | (38,248) | ​ | $ | (2,274) | ​ | $ | 539,471
Net loss | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | (12,205) | ​ | ​ | — | ​ |  | (12,205)
Shares of common stock issued under the ESPP | ​ | ​ | 129,928 | ​ | ​ | — | ​ | ​ | 214 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 214
Witholding of employee taxes related to stock-based compensation | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (111) | ​ | ​ | 84 | ​ | ​ | — | ​ | ​ | (27)
Shares of common stock issued for vested RSUs | ​ | ​ | 163,148 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock options exercised | ​ |  | 346,676 | ​ |  | — | ​ | ​ | 33 | ​ |  | — | ​ | ​ | — | ​ |  | 33
Stock-based compensation expense | ​ |  | — | ​ |  | — | ​ | ​ | 2,923 | ​ |  | — | ​ | ​ | — | ​ |  | 2,923
Unrealized loss on marketable securities | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,098) | ​ | ​ | (1,098)
Balance as of June 30, 2023 | ​ | ​ | 178,326,890 | ​ | $ | 18 | ​ | $ | 583,034 | ​ | $ | (50,369) | ​ | $ | (3,372) | ​ | $ | 529,311

​

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

​

​

7

Table of Contents

Solid Power, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six Months Ended June 30, | ​
​ |  | 2024 |  | 2023 | ​
Cash Flows from Operating Activities |  | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (43,481) | ​ | $ | (31,365) | ​
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities: | ​ | ​ | ​ | ​ |  | ​ | ​
Depreciation and amortization | ​ | ​ | 7,974 | ​ |  | 4,906 | ​
Amortization of right-of-use assets | ​ | ​ | 417 | ​ | ​ | 372 | ​
Stock-based compensation expense | ​ | ​ | 5,914 | ​ |  | 5,145 | ​
Change in fair value of warrant liabilities | ​ | ​ | (202) | ​ | ​ | (2,325) | ​
Accretion of discounts on other long-term liabilities | ​ | ​ | 24 | ​ | ​ | — | ​
Amortization of premiums and accretion of discounts on marketable securities | ​ | ​ | (4,540) | ​ | ​ | (5,518) | ​
Change in operating assets and liabilities that provided (used) cash and cash equivalents: | ​ | ​ | ​ | ​ |  | ​ | ​
Contract receivables | ​ | ​ | (6,213) | ​ |  | (1,232) | ​
Contract receivables from related parties | ​ | ​ | (4,581) | ​ | ​ | (2,151) | ​
Prepaid expenses and other assets | ​ | ​ | (2,287) | ​ |  | (188) | ​
Accounts payable and other accrued liabilities | ​ | ​ | 884 | ​ |  | (297) | ​
Deferred revenue | ​ | ​ | 10,075 | ​ |  | (32) | ​
Deferred revenue from related parties | ​ | ​ | (828) | ​ | ​ | (4,000) | ​
Accrued compensation | ​ | ​ | (3,030) | ​ |  | 649 | ​
Operating lease liabilities | ​ | ​ | (305) | ​ | ​ | (268) | ​
Net cash and cash equivalents used in operating activities | ​ | ​ | (40,179) | ​ |  | (36,304) | ​
Cash Flows from Investing Activities | ​ | ​ | ​ | ​ |  | ​ | ​
Purchases of property, plant and equipment | ​ | ​ | (8,460) | ​ |  | (21,184) | ​
Purchases of marketable securities and investments | ​ | ​ | (99,548) | ​ |  | (174,400) | ​
Proceeds from sales of marketable securities and investments | ​ | ​ | 156,135 | ​ | ​ | 210,329 | ​
Cash paid for note receivable to an independent contractor | ​ | ​ | (3,046) | ​ | ​ | — | ​
Purchases of intangible assets | ​ | ​ | (270) | ​ |  | (259) | ​
Net cash and cash equivalents provided by investing activities | ​ | ​ | 44,811 | ​ |  | 14,486 | ​
Cash Flows from Financing Activities | ​ | ​ | ​ | ​ |  | ​ | ​
Payments of debt | ​ | ​ | — | ​ |  | (7) | ​
Proceeds from exercise of stock options | ​ | ​ | 197 | ​ |  | 184 | ​
Proceeds from issuance of shares of common stock under the ESPP | ​ | ​ | 238 | ​ | ​ | 214 | ​
Cash paid for withholding of employee taxes related to stock-based compensation | ​ | ​ | (479) | ​ | ​ | (111) | ​
Repurchase of shares of common stock | ​ | ​ | (8,274) | ​ | ​ | — | ​
Payments on finance lease liabilities | ​ | ​ | (213) | ​ | ​ | (146) | ​
Net cash and cash equivalents provided by (used in) financing activities | ​ | ​ | (8,531) | ​ | ​ | 134 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net decrease in cash and cash equivalents | ​ | ​ | (3,899) | ​ | ​ | (21,684) | ​
Cash and cash equivalents at beginning of period | ​ | ​ | 34,537 | ​ | ​ | 50,123 | ​
Cash and cash equivalents at end of period | ​ | ​ | 30,638 | ​ | ​ | 28,439 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash paid for interest | ​ | $ | 91 | ​ | $ | 26 | ​
Accrued capital expenditures | ​ | $ | 744 | ​ | $ | 3,591 | ​

​

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

​

8

Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (in thousands, except number of shares and per share amounts)

Note 1 – Nature of Business

Solid Power is developing solid-state battery technology for the EV and other markets. The Company’s planned business model is to manufacture and sell its proprietary electrolyte and to license its cell designs and manufacturing processes.

Note 2 – Significant Accounting Policies

The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company’s financial statements included in the 2023 Form 10-K and are supplemented by the Notes. The financial statements included in this Report (including the Notes) should be read in conjunction with the 2023 Form 10-K.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of GAAP and reflect all adjustments of a normal recurring nature, which are, in the opinion of management, necessary for a fair presentation of the consolidated financial position and results of operations at, and for, the periods presented. The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value and share and per share amounts.

The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

Income Taxes

In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures. ASU 2023-09 requires companies to disclose, on an annual basis, specific categories in the effective tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. In addition, ASU 2023-09 requires companies to disclose additional information about income taxes paid. ASU 2023-09 will be effective for annual periods beginning January 1, 2025 and will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is evaluating the disclosure impact of ASU 2023-09.

Segment Reporting

In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. Among other new disclosure requirements, ASU 2023-07 requires companies to disclose significant segment expenses that are regularly provided to the chief operating decision maker, or CODM. ASU 2023-07 will be effective for annual periods beginning on January 1, 2024 and interim periods beginning on January 1, 2025. ASU 2023-07 must be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect any financial statement impact with the adoption of ASU 2023-07.

9

Table of Contents

Note 3 – Property, Plant and Equipment

Property, plant and equipment are summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2024 |  | December 31, 2023 | ​
Production equipment | ​ | $ | 36,473 | ​ | $ | 36,086 | ​
Laboratory equipment | ​ | ​ | 11,275 | ​ | ​ | 9,910 | ​
Leasehold improvements | ​ |  | 59,394 | ​ |  | 59,109 | ​
Furniture and computer equipment | ​ |  | 4,046 | ​ |  | 3,915 | ​
Construction in progress | ​ |  | 20,015 | ​ |  | 13,650 | ​
Total cost | ​ |  | 131,203 | ​ |  | 122,670 | ​
Accumulated depreciation | ​ |  | (31,476) | ​ |  | (23,514) | ​
Net property and equipment | ​ | $ | 99,727 | ​ | $ | 99,156 | ​

​

Depreciation expenses for dedicated laboratory equipment and production equipment are charged to research and development. The other depreciation expenses are included in the Company’s overhead and are allocated across Operating Expenses based on Company personnel costs incurred.

Depreciation expense related to property, plant and equipment are summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30, | ​
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023 | ​
Depreciation expense | ​ | $ | 4,061 | ​ | $ | 2,639 | ​ | $ | 7,966 | ​ | $ | 4,898 | ​

​

The Company expanded its electrolyte production to produce larger quantities of electrolyte material required to feed cell-production lines and continue research and development efforts at SP2. The Company began producing electrolyte at SP2 in 2023. The Company is developing a design verification plan and report lab at SP2 to improve and test process developments, which is anticipated to be placed in service by the end of 2024.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Construction in progress | ​ | June 30, 2024 | ​ | December 31, 2023 | ​
SP1 - Capital projects | ​ | $ | 3,797 | ​ | $ | 2,298 | ​
SP2 - Increased scale electrolyte production | ​ | ​ | 16,218 | ​ | ​ | 11,352 | ​
Total | ​ | $ | 20,015 | ​ | $ | 13,650 | ​

​

​

Note 4 – Intangible Assets

Intangible assets of the Company are summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2024 |  | December 31, 2023 | ​
​ | ​ | Gross Carrying | ​ | Accumulated | ​ | Gross Carrying | ​ | Accumulated | ​
​ |  | Amount |  | Amortization |  | Amount |  | Amortization | ​
Intangible assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Licenses | ​ | $ | 149 | ​ | $ | (65) | ​ | $ | 149 | ​ | $ | (61) | ​
Patents | ​ | ​ | 130 | ​ | ​ | (8) | ​ | ​ | 92 | ​ | ​ | (5) | ​
Patents pending |  | ​ | 1,671 |  | ​ | ​ |  | ​ | 1,444 |  | ​ | — | ​
Trademarks | ​ | ​ | 13 | ​ | ​ | ​ | ​ | ​ | 13 | ​ | ​ | — | ​
Trademarks pending |  | ​ | 22 |  | ​ | ​ |  | ​ | 18 |  | ​ | — | ​
Total amortized intangible assets | ​ | $ | 1,985 | ​ | $ | (73) | ​ | $ | 1,716 | ​ | $ | (66) | ​

​

​

10

Table of Contents

Amortization expense for intangible assets is summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30, |
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023 |
Amortization expense | ​ | $ | 3 | ​ | $ | 3 | ​ | $ | 7 | ​ | $ | 8 | ​

​

Useful lives of intangible assets range from three to 20 years. Amortization expenses are allocated ratably across Operating Expenses based on Company personnel costs incurred.

Note 5 – Collaborative Arrangement

On January 10, 2024, the Company entered into the SK On Agreements. The Company determined the SK On Agreements should be combined and evaluated as a single contract. The SK On Agreements were determined to be a collaborative arrangement in accordance with ASC Topic 808, Collaborative Arrangements, and revenue recognition is recorded by analogy to ASC Topic 606, Revenue from Contracts with Customers. The Company determined the SK On Agreements represent a single, combined performance obligation. Collaborative revenue is recognized over time using the input measurement method utilizing incurred labor hours in relation to total labor hours anticipated to satisfy the combined performance obligation. The Company will expense contract fulfillment costs as incurred.

​

Note 6 – Fair Value Measurements

The Company considers all highly liquid instruments with original maturities of less than 90 days to be cash equivalents. The carrying amounts of certain financial instruments, such as cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities.

Level 1inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that a reporting entity can access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities.

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

As of June 30, 2024 and December 31, 2023, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2024
​ |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Commercial Paper | ​ | $ | 81,021 | ​ | $ | — | ​ | $ | — | ​ | $ | 81,021
Corporate Bonds | ​ | $ | 203,592 | ​ | $ | — | ​ | $ | — | ​ | $ | 203,592
Government Bonds | ​ | $ | 43,582 | ​ | $ | — | ​ | $ | — | ​ | $ | 43,582
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Public Warrants | ​ | $ | 2,241 | ​ | $ | — | ​ | $ | — | ​ | $ | 2,241
Private Placement Warrants | ​ | $ | — | ​ | $ | 1,784 | ​ | $ | — | ​ | $ | 1,784

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2023
​ |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Commercial Paper | ​ | $ | 84,909 | ​ | $ | — | ​ | $ | — | ​ | $ | 84,909
Corporate Bonds | ​ | $ | 239,473 | ​ | $ | — | ​ | $ | — | ​ | $ | 239,473
Government Bonds | ​ | $ | 56,689 | ​ | $ | — | ​ | $ | — | ​ | $ | 56,689
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Public Warrants | ​ | $ | 2,505 | ​ | $ | — | ​ | $ | — | ​ | $ | 2,505
Private Placement Warrants | ​ | $ | — | ​ | $ | 1,722 | ​ | $ | — | ​ | $ | 1,722

​

11

Table of Contents

The change in fair value of the Company’s marketable securities and investments are included in other comprehensive income (loss). There were no transfers in and out of Level 3 fair value hierarchy during the three or six months ended June 30, 2024 or year ended December 31, 2023. During the six months ended June 30, 2024, the Company purchased $99,548 of marketable securities and investments.

Fair Value of Warrants

The fair value of the Private Placement Warrants has been estimated using a Black-Scholes model as of June 30, 2024 and December 31, 2023 Consolidated Balance Sheet dates. The estimated fair value of the Private Placement Warrants is determined using Level 2 directly or indirectly observable inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company’s Public Warrants and from historical volatility of the Company’s common stock. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The fair value of the Public Warrants has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input.

The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2024 |  | December 31, 2023 |
Exercise price | ​ | $ | 11.50 | ​ | $ | 11.50 | ​
Stock price | ​ | $ | 1.65 | ​ | $ | 1.45 | ​
Volatility | ​ |  | 97.9 | % |  | 95.0 | %
Term (in years) | ​ |  | 2.44 | ​ |  | 2.94 | ​
Risk-free rate | ​ |  | 4.52 | % |  | 3.94 | %

​

The following table provides a rollforward of the Public Warrants measured at fair value per Public Warrant using Level 1 inputs and Private Placement Warrants measured at fair value per Private Placement Warrant using Level 2 inputs:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Public Warrants | ​ | Private Placement Warrants
​ |  | Level 1 Fair Value |  | Level 2 Fair Value
December 31, 2023 | ​ | $ | 0.19 | ​ | $ | 0.28
Change in fair value | ​ | $ | 0.01 | ​ | $ | 0.06
March 31, 2024 | ​ | $ | 0.20 | ​ | $ | 0.34
Change in fair value | ​ | $ | (0.03) | ​ | $ | (0.05)
June 30, 2024 | ​ | $ | 0.17 | ​ | $ | 0.29

​

The following tables provides a reconciliation of the change in fair value for the Public Warrants and Private Placement Warrants for the three months ended June 30, 2024:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Three Months Change in | ​ | ​
Warrant Class |  | Level |  | Warrants |  | March 31, 2024 |  | Fair Value |  | June 30, 2024
Public Warrants |  | 1 |  | 13,182,501 | ​ | $ | 2,637 | ​ | $ | (396) | ​ | $ | 2,241
Private Placement Warrants |  | 2 |  | 6,150,802 | ​ | $ | 2,091 | ​ | $ | (307) | ​ | $ | 1,784
Total |  |  |  | 19,333,303 | ​ | $ | 4,728 | ​ | $ | (703) | ​ | $ | 4,025

​

The following tables provides a reconciliation of the change in fair value for the Public Warrants and Private Placement Warrants for the six months ended June 30, 2024:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Six Months Change in | ​ | ​
Warrant Class |  | Level |  | Warrants |  | December 31, 2023 |  | Fair Value |  | June 30, 2024
Public Warrants |  | 1 |  | 13,182,501 | ​ | $ | 2,505 | ​ | $ | (264) | ​ | $ | 2,241
Private Placement Warrants |  | 2 |  | 6,150,802 | ​ | $ | 1,722 | ​ | $ | 62 | ​ | $ | 1,784
Total |  |  |  | 19,333,303 | ​ | $ | 4,227 | ​ | $ | (202) | ​ | $ | 4,025

​

​

​

​

​

​

​

​

​

​

​

12

Table of Contents

Note 7 – Warrant Liabilities

The table below provides a summary of the outstanding Public and Private Placement Warrants at:

​

​ | ​ | ​ | ​ | ​
​ |  | June 30, 2024 |  | December 31, 2023
Public Warrants | ​ | 13,182,501 | ​ | 13,182,501
Private Placement Warrants | ​ | 6,150,802 | ​ | 6,150,802

​

Each whole Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.

None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. The table below provides the fair value of warrant liabilities at:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | June 30, 2024 |  | ​ | December 31, 2023
Fair value of warrant liabilities | ​ | $ | 4,025 | ​ | $ | 4,227

​

The table below provides the Company’s loss recognized in connection with changes in fair value of warrant liabilities:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Six Months Ended June 30,
​ |  | ​ | 2024 | ​ |  | 2023 | ​
Gain recognized associated with warrant liabilities | ​ | $ | 202 | ​ | $ | 2,325 | ​

​

There have been no changes to our Public or Private Placement Warrants, including redemption terms disclosed in our 2023 Form 10-K.

Note 8 – Stockholders’ Equity

Common Stock

Stock options exercised for common stock, shares of common stock repurchased under the stock repurchase program, shares of common stock issued under the ESPP, and shares of common stock issued upon vesting of RSUs for the three and six months ended June 30, 2024 and 2023 are summarized in the table below:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30, | ​
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023 | ​
Stock options exercised | ​ | 1,230,581 | ​ | 346,676 | ​ | 3,590,897 | ​ | 2,026,630 | ​
Shares of common stock repurchased | ​ | (1,816,362) | ​ | — | ​ | (5,000,000) | ​ | — | ​
Shares of common stock issued under the ESPP | ​ | 187,614 | ​ | 129,928 | ​ | 187,614 | ​ | 129,928 | ​
Shares of common stock issued for vested RSUs | ​ | 689,221 | ​ | 163,148 | ​ | 851,216 | ​ | 163,148 | ​

​

The table below presents the cash received or paid associated with common stock related activities for the three and six months ended June 30, 2024 and 2023:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Three Months Ended June 30, | ​ | ​ | Six Months Ended June 30,
​ |  | 2024 | ​ |  | 2023 | ​ |  | 2024 |  |  | 2023
Cash received from stock options exercised | $ | 100 | ​ | $ | 34 | ​ | $ | 197 | ​ | $ | 184
Cash received from shares of common stock issued under the ESPP | ​ | 238 | ​ | ​ | 214 | ​ | ​ | 238 | ​ | ​ | 214
Cash paid for shares of common stock repurchased | ​ | (3,360) | ​ | ​ | — | ​ | ​ | (8,274) | ​ | ​ | —

​

13

Table of Contents

Stock Repurchase Program

On January 23, 2024, the Company announced that its Board approved a stock repurchase program authorizing the Company to purchase up to $50,000 of the Company’s outstanding common stock. Under the repurchase program, the Company may purchase shares of its common stock from time to time until the repurchase program expires on December 31, 2025.

The table below presents the number of shares repurchased and retired, the aggregate cost, and the average purchase price per share for the three months ended June 30, 2024:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | Shares | ​ | ​ | Aggregate cost |  | ​ | Avg. Price Paid Per Share
Repurchased and retired shares of common stock | ​ | ​ | 1,816,362 | ​ | $ | 3,393 | ​ | $ | 1.85

​

The table below presents the number of shares repurchased and retired, the aggregate cost, and the average purchase price per share for the six months ended June 30, 2024:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | Shares | ​ | ​ | Aggregate cost |  | ​ | Avg. Price Paid Per Share
Repurchased and retired shares of common stock | ​ | ​ | 5,000,000 | ​ | $ | 8,355 | ​ | $ | 1.64

​

​

​

Note 9 – Stock-Based Compensation

There have been no changes to our equity incentive plans, the ESPP, or our accounting methodology for stock-based compensation, as disclosed in our 2023 Form 10-K.

The fair value of stock options and RSUs issued to employees and directors is recognized as compensation expense over the period of service that generally coincides with the vesting period of the award. The Company allocated compensation ratably across Operating Expenses based on Company personnel costs incurred. When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.

For the three and six months ended June 30, 2024 and 2023, the Company recognized compensation costs totaling:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023
Stock-based compensation costs related to RSUs | ​ | $ | 1,397 | ​ | $ | 954 | ​ | $ | 2,609 | ​ | $ | 1,589
Stock-based compensation costs related to stock options | ​ |  | 1,612 | ​ |  | 1,889 | ​ |  | 3,226 | ​ |  | 3,476
Stock-based compensation costs related to the ESPP | ​ | ​ | 42 | ​ | ​ | 80 | ​ | ​ | 79 | ​ | ​ | 80
Total stock-based compensation costs | ​ | $ | 3,051 | ​ | $ | 2,923 | ​ | $ | 5,914 | ​ | $ | 5,145

​

The unrecognized future compensation costs as of June 30, 2024 and 2023, were $25,868 and $34,327, respectively.

The following table summarizes our award activity for RSUs and stock options for the three and six months ended June 30, 2024:

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | ​
​ | ​ | RSUs | ​ | Stock Options
Balance at December 31, 2023 | ​ | 4,473,016 |  | ​ | 24,264,016
Granted | ​ | 3,159,872 | ​ | ​ | 4,566,167
Vested or Exercised | ​ | (264,754) | ​ | ​ | (2,360,316)
Forfeited | ​ | (72,619) | ​ | ​ | (842,395)
Balance at March 31, 2024 | ​ | 7,295,515 | ​ | ​ | 25,627,472
Granted | ​ | 2,162,222 | ​ | ​ | 1,757,960
Vested or Exercised | ​ | (867,515) | ​ | ​ | (1,230,581)
Forfeited | ​ | (886,343) | ​ | ​ | (1,873,843)
Balance at June 30, 2024 | ​ | 7,703,879 | ​ | ​ | 24,281,008

​

​

14

Table of Contents

​

Stock Options

The fair value of each stock option grant during the six months ended June 30, 2024 and 2023 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six Months Ended June 30, |  | ​
​ |  | 2024 |  | 2023 |  | ​
Approximate risk‑free rate |  | ​ | 4.23 | % | ​ | 4.17 | % | ​
Volatility |  | ​ | 48.10 | % | ​ | 46.91 | % | ​
Average expected life (in years) |  | ​ | 6 | ​ | ​ | 6 | ​ | ​
Dividend yield |  | ​ | — | % | ​ | — | % | ​
Weighted‑average grant date fair value | ​ | $ | 1.59 | ​ | $ | 2.8 | ​ | ​
Estimated fair value of total stock options granted | ​ | $ | 5,175 | ​ | $ | 7,815 | ​ | ​

​

​

Note 10 – Basic and Diluted Loss Per Share

Basic loss per share represents net loss attributable to common stock divided by the basic weighted average number of shares of common stock outstanding during the period.

Diluted loss per share also includes the dilutive effect of additional potential shares of common stock issuable from stock-based awards determined using the treasury stock method. Diluted loss per share represents net earnings divided by diluted weighted average number of shares of common stock, which includes the average dilutive effect of all potentially dilutive securities that are outstanding during the period.

The table below sets forth the basic and diluted loss per share calculation for the three and six months ended June 30, 2024 and 2023.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30, | ​
​ |  | 2024 | ​ | 2023 | ​ | 2024 | ​ | 2023 | ​
Net loss attributable to common stockholders | ​ | $ | (22,274) | ​ | $ | (12,205) | ​ | $ | (43,481) | ​ | $ | (31,365) | ​
Weighted average shares outstanding – basic and diluted | ​ | ​ | 177,588,035 | ​ | ​ | 178,063,573 | ​ | ​ | 179,186,027 | ​ | ​ | 177,502,037 | ​
Basic and diluted loss per share | ​ | $ | (0.13) | ​ | $ | (0.07) | ​ | $ | (0.24) | ​ | $ | (0.18) | ​

​

Due to the net loss for the three and six months ended June 30, 2024 and 2023 presented above, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. The table below sets forth (in shares) potentially dilutive securities excluded from the diluted loss per share calculation for the three and six months ended June 30, 2024 and 2023.

​

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six Months Ended June 30, | ​
​ | ​ | 2024 |  | 2023 | ​
Warrants | ​ | 19,333,303 |  | 19,333,303 | ​
2014 Plan & 2021 Plan - Stock Options | ​ | 23,508,745 |  | 25,892,666 | ​
2021 Plan - RSUs | ​ | 6,269,774 |  | 2,474,393 | ​
ESPP - Common Stock | ​ | 46,946 | ​ | 46,352 | ​
Contingently Issued Shares of Common Stock | ​ | — | ​ | 59,055 | ​
Total potentially dilutive securities | ​ | 49,158,768 | ​ | 47,805,769 | ​

​

​

Note 11 – Leases

The Company leases its facilities and certain equipment. Fixed rent escalates each year, and the Company is responsible for a portion of the landlords’ operating expenses such as property tax, insurance, and common area maintenance.

The Company’s facility in Louisville, Colorado, is under a noncancelable operating lease with a maturity date in September 2029. In 2022, the Company amended this operating lease to incorporate a prior subleased space into the base lease and extend the term of the lease. The Company has the right to renew this operating lease for an additional five-year period.

15

Table of Contents

On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew for five years, which has been included in the calculation of lease liabilities and right-of-use assets at the adoption date of the lease accounting standard on January 1, 2022, as the exercise of the option was reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.

The Company has certain equipment leases classified as finance leases as of June 30, 2024.

The Company’s leases do not have any contingent rent payments and do not contain residual value guarantees.

The components of lease expense are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended June 30, |  | Six Months Ended June 30, | ​
​ |  | 2024 | ​ | 2023 |  | 2024 | ​ | 2023 | ​
Finance lease costs: |  | ​ |  | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​
Amortization of right-of-use assets | ​ | $ | 58 | ​ | $ | 47 | ​ | $ | 116 | ​ | $ | 91 | ​
Interest on lease liabilities | ​ |  | 12 | ​ |  | 13 | ​ |  | 26 | ​ |  | 25 | ​
Operating lease costs | ​ |  | 290 | ​ |  | 290 | ​ |  | 580 | ​ |  | 580 | ​
Total lease expense | ​ | $ | 360 | ​ | $ | 350 | ​ | $ | 722 | ​ | $ | 696 | ​

​

The components of cash flow information related to leases are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended June 30, |  | Six Months Ended June 30, | ​
​ |  | 2024 | ​ | 2023 |  | 2024 | ​ | 2023 | ​
Operating outgoing cash flows – finance leases | ​ | $ | 13 | ​ | $ | 14 | ​ | $ | 27 | ​ | $ | 26 | ​
Financing outgoing cash flows – finance leases | ​ |  | 94 | ​ |  | 74 | ​ |  | 186 | ​ |  | 141 | ​
Operating outgoing cash flows – operating leases | ​ |  | 292 | ​ |  | 283 | ​ |  | 584 | ​ |  | 567 | ​
Right-of-use assets obtained in exchange for new finance lease liabilities: | ​ | ​ | — | ​ | ​ | 79 | ​ | ​ | — | ​ | ​ | 89 | ​
Right-of-use assets obtained in exchange for new operating lease liabilities: | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​

​

​

​ | ​ | ​ | ​
​ |  | June 30, 2024 |
Finance lease |  |  | ​
Weighted-average remaining lease term – finance leases (in years) |  | 2.47 | ​
Weighted-average discount rate – finance leases |  | 6.6 | %
Operating lease |  | ​ | ​
Weighted-average remaining lease term – operating leases (in years) |  | 8.75 | ​
Weighted-average discount rate – operating leases |  | 6.8 | %

​

As of June 30, 2024, future minimum payments during the next five years and thereafter are as follows:

​ | ​ | ​ | ​ | ​ | ​ | ​
Fiscal year |  | Finance Lease |  | Operating Lease
2024 (remaining six months) | ​ | $ | 212 | ​ | $ | 589
2025 | ​ | ​ | 310 | ​ | ​ | 1,210
2026 | ​ | ​ | 179 | ​ | ​ | 1,248
2027 | ​ | ​ | 85 | ​ | ​ | 1,288
2028 | ​ | ​ | 16 | ​ | ​ | 1,329
2029 | ​ | ​ | — | ​ | ​ | 1,211
Thereafter | ​ | ​ | — | ​ | ​ | 4,031
Total | ​ | ​ | 802 | ​ | ​ | 10,906
Less present value discount | ​ | ​ | (59) | ​ | ​ | (2,589)
Total lease liabilities | ​ | $ | 743 | ​ | $ | 8,317

​

​

16

Table of Contents

Note 12 – Related Party Transactions

During the three and six months ended June 30, 2024, the Company recognized $430 and $5,410 of revenue related to the BMW JDA, respectively. As of June 30, 2024, the Company recorded $4,581 of accounts receivable related to the BMW JDA. During the three and six months ended June 30, 2023, the Company recognized $3,470 and $6,470 of revenue related to the BMW JDA, respectively. For the year ended December 31, 2023, the Company recorded $828 of deferred revenue related to cash paid from BMW in advance of services provided.

On June 21, 2024, Solid Power Operating, Inc., a wholly owned subsidiary of the Company, amended its JDA with BMW to extend the term of the JDA and revise the payment schedule.

Note 13 – Income Taxes

The Company’s effective tax rate was (2.4%) and (1.2%) for the three and six months ended June 30, 2024, respectively, as a result of withholding tax expense on revenue earned in a foreign jurisdiction. The Company’s effective tax rate was 0% for the three and six months ended June 30, 2023, and the Company was in a full valuation allowance for the three and six months ended June 30, 2024 and 2023.

The Company's quarterly provision for income taxes is calculated by applying a projected annual effective tax rate, calculated separately for the United States and Republic of Korea, to ordinary pre-tax book income.

Note 14 – Contingencies

In the normal course of business, the Company may be party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

​

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this Report. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs, and expected performance. For additional discussion, see “Cautionary Note Regarding Forward-Looking Statements” above. The forward-looking statements are dependent upon events, risks, and uncertainties that may be outside of our control. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed elsewhere in this Report and under “Part I, Item 1A. Risk Factors” of our 2023 Form 10-K, as such descriptions may be updated or amended in future filings we make with the SEC. Unless indicated otherwise, the following discussion and analysis of results of operations and financial condition and liquidity relates to our current continuing operations and should be read in conjunction with the consolidated financial statements and notes thereto of this Report and our 2023 Form 10-K. We do not undertake, and expressly disclaim, any obligation to publicly update any forward-looking statements, whether as a result of new information, new developments, or otherwise, except to the extent that such disclosure is required by applicable law.

Overview

Solid Power is developing solid-state battery technology for the EV market and additional markets served by battery manufacturers.

Our core technology is our proprietary solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion batteries. We believe that our electrolyte material can improve driving range, battery life, safety performance, and battery costs.

We are also developing solid-state cells with our electrolyte, with the aim of commercializing our technology by selling our electrolyte material and licensing our cell designs. This approach minimizes capital requirements, unlike other battery manufacturers who require significant production facilities and equipment. Also, this strategy allows us to focus on our core strengths of electrolyte production and solid-state technology development.

17

Table of Contents

The Company currently produces electrolyte on a pilot manufacturing line, which is used in cell development and for customer sampling. We currently develop our cells on our two pilot lines, producing multiple cell sizes to both support our partners and refine cell designs. Longer-term, we expect the pilot lines to focus on research and development.

We have partnered with industry leaders BMW, Ford Motor Company, and SK On and will continue to work closely with our partners to improve cell designs, produce electrolyte material, and commercialize our technology. Our products are currently in the development stage and require further research and improvement before we can commercialize our technology.

Recent Business Highlights

| ● | Received positive feedback from increased electrolyte sampling and made shipments to potential customers.

| ● | Successfully completed the first milestone on our R&D License Agreement and made significant progress on deliverables under the Line Installation Agreement with SK On.

| ● | Continued advancements in A-2 sample cell designs and execution on agreements with partners as we continue to have a strong balance sheet to execute the Company’s strategy.

| ● | Appointed Linda Heller as Chief Financial Officer and Treasurer.

Key Factors Affecting Operating Results

We are a research and development-stage company and have not generated significant revenue through the sale of our electrolyte or licensing of our cell designs. Our ability to commercialize our products depends on several factors that present significant opportunities for us but also pose material risks and challenges, including those discussed in the “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” sections of this Report, which are incorporated by reference.

Prior to reaching commercialization, the Company must improve our products to ensure they meet the performance and safety requirements of our customers. We also will have to continue to negotiate licensing and supply contracts with our customers on terms and conditions that are mutually acceptable. Production of our electrolyte material will need to be scaled to satisfy anticipated demand. All of these factors will take time and affect our operating results. Since many factors are difficult to quantify, actual operating results may be different than currently anticipated.

Revenue generated to date has primarily come from performance on research and development licensing activities and government contracts. Substantial capital will need to be deployed to expand our production capabilities and engage in research and development programs. We also expect to continue to incur significant administrative expenses as a publicly traded company.

In addition to meeting development goals, commercialization and future growth and demand for our products are highly dependent upon consumers adopting EVs. The market for new energy vehicles is still rapidly evolving due to emerging technologies, competitive pricing, government regulation and industry standards, and changing consumer demands and behaviors.

Basis of Presentation

We currently conduct our business through one operating segment. As a research and development company with no commercial operations, our activities to date have been limited and were conducted primarily in the United States. Historical results are reported under GAAP and in U.S. dollars.

Results of Operations

Comparison of the Three and Six Months Ended June 30, 2024 to the Three and Six Months Ended June 30, 2023

During the three and six months ended June 30, 2024, development efforts were expanded and accelerated through increased capital and operational investments. We continued to invest in talent while expanding our facilities, production equipment, and capabilities. This trend is expected to continue for our production capabilities, partnership development, and Korean operations through the remainder of 2024 as the development strategy is executed according to the current outlook.

18

Table of Contents

The following table is a consolidated summary of our operating results for the periods indicated:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | ​ | ​ | ​ | ​ |  | ​ | Six Months Ended June 30, | ​ | ​ | ​ | ​ | ​ |  | ​
(in thousands) |  | 2024 |  | 2023 |  | Change |  | % |  |  | 2024 |  | 2023 |  | Change |  | % |  | ​
Revenue | ​ | $ | 5,075 | ​ | $ | 4,906 | ​ | $ | 169 | ​ | 3 | % | ​ | $ | 11,028 | ​ | $ | 8,698 | ​ | $ | 2,330 | ​ | 27 | % | ​
Operating Expenses | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  |  |  |  | ​ | ​
Direct costs | ​ | ​ | 5,437 | ​ | ​ | 6,897 | ​ |  | (1,460) |  | (21) | % | ​ |  | 9,727 | ​ | ​ | 13,171 | ​ |  | (3,444) |  | (26) | % | ​
Research and development | ​ | ​ | 18,526 | ​ |  | 14,508 | ​ |  | 4,018 |  | 28 | % | ​ |  | 37,400 | ​ | ​ | 26,156 | ​ |  | 11,244 |  | 43 | % | ​
Selling, general and administrative | ​ | ​ | 8,049 | ​ |  | 5,673 | ​ |  | 2,376 |  | 42 | % | ​ |  | 16,619 | ​ | ​ | 12,862 | ​ |  | 3,757 |  | 29 | % | ​
Total operating expenses | ​ | ​ | 32,012 | ​ |  | 27,078 | ​ |  | 4,934 |  | 18 | % | ​ |  | 63,746 | ​ | ​ | 52,189 | ​ |  | 11,557 |  | 22 | % | ​
Operating Loss | ​ | ​ | (26,937) | ​ |  | (22,172) | ​ |  | (4,765) |  | (21) | % | ​ |  | (52,718) | ​ | ​ | (43,491) | ​ |  | (9,227) |  | (21) | % | ​
Nonoperating Income and Expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  |  |  |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  |  |  |  | ​ | ​
Interest income | ​ | ​ | 4,520 | ​ | ​ | 4,993 | ​ |  | (473) |  | (9) | % | ​ |  | 9,637 | ​ | ​ | 9,827 | ​ |  | (190) |  | (2) | % | ​
Change in fair value of warrant liabilities | ​ | ​ | 703 | ​ | ​ | 4,987 | ​ | ​ | (4,284) | ​ | (86) | % | ​ | ​ | 202 | ​ | ​ | 2,325 | ​ | ​ | (2,123) | ​ | (91) | % | ​
Interest expense | ​ | ​ | (49) | ​ | ​ | (13) | ​ |  | (36) |  | 277 | % | ​ |  | (91) | ​ | ​ | (26) | ​ |  | (65) |  | (250) | % | ​
Total nonoperating income and expense | ​ | ​ | 5,174 | ​ |  | 9,967 | ​ | $ | (4,793) |  | (48) | % | ​ | $ | 9,748 | ​ | ​ | 12,126 | ​ | $ | (2,378) |  | (20) | % | ​
Pretax Loss | ​ | $ | (21,763) | ​ | $ | (12,205) | ​ | $ | (9,558) |  | 78 | % | ​ | $ | (42,970) | ​ | $ | (31,365) | ​ | $ | (11,605) |  | 37 | % | ​
Income tax expense | ​ | ​ | 511 | ​ | ​ | — | ​ | $ | 511 |  | NM | ​ | ​ | $ | 511 | ​ | ​ | — | ​ | $ | 511 |  | NM | ​ | ​
Net Loss Attributable to Common Stockholders | ​ | $ | (22,274) | ​ | $ | (12,205) | ​ | $ | (10,069) |  | 82 | % | ​ | $ | (43,481) | ​ | $ | (31,365) | ​ | $ | (12,116) |  | (39) | % | ​
Other Comprehensive Income (Loss) | ​ | ​ | (11) | ​ | ​ | 1,098 | ​ | ​ | (1,109) |  | NM | ​ | ​ |  | (590) | ​ | ​ | (213) | ​ | ​ | (377) |  | 177 | % | ​
Comprehensive Loss Attributable to Common Stockholders | ​ | $ | (22,285) | ​ | $ | (11,107) | ​ | $ | (11,178) |  | 101 | % | ​ | $ | (44,071) | ​ | $ | (31,578) | ​ | $ | (12,493) |  | (40) | % | ​

​

NM = Not meaningful

The key factors driving results of operations for the three and six months ended June 30, 2024, including the increased operating loss as compared to the corresponding period in 2023, were as follows:

| ● | Revenue increased for the periods, as compared to 2023, primarily as a result of continued execution on our collaborative arrangements and government contracts. Revenue for 2024 is anticipated to be stable, as compared to 2023, due to fewer active government contracts in 2024 and completion of milestones under our JDAs and collaborative arrangements in the first half of 2024 offset by the commencement of the SK On collaborative arrangement.

| ● | Direct costs decreased for the periods, as compared to 2023, principally as a result of early completion of milestones under our collaborative arrangements and government contracts in the prior period. Direct costs are anticipated to decrease for 2024, as compared to 2023, due to fewer active government contracts in 2024 and completion of milestones under our JDAs and collaborative arrangements in the first half of 2024.

| ● | Research and development costs increased for the periods mainly as a result of expanded development and production efforts of our electrolyte and EV cells resulting in increased production and labor costs. We expect our research and development costs to increase in the remainder of 2024, as compared to 2023, as the pace and scope of development and production efforts continue to increase.

| ● | Selling, general and administrative expenses increased for the periods primarily due to additional planned hiring, workforce development, and retention awards. We expect selling, general and administrative expenses to increase in the remainder of 2024, as compared to 2023, as a result of additional planned hiring and workforce development to, among other things, support Korean operations.

| ● | Nonoperating income decreased for the periods due to a lesser gain on fair value adjustment of warrant liabilities and a decrease in interest income as compared to 2023.

​

​

19

Table of Contents

Liquidity and Capital Resources

Sources of Liquidity

The Company’s primary sources of cash have historically been derived from the sale of equity, with a smaller portion coming from performance milestones on our collaborative arrangements and government contracts.

As of June 30, 2024 and December 31, 2023, we had total liquidity, as set forth below:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(in thousands) |  | June 30, 2024 | ​ | December 31, 2023 | ​
Cash and cash equivalents | ​ | $ | 30,638 | ​ | $ | 34,537 | ​
Marketable securities | ​ |  | 109,882 | ​ |  | 141,505 | ​
Investments | ​ |  | 218,313 | ​ |  | 239,566 | ​
Total liquidity | ​ | $ | 358,833 | ​ | $ | 415,608 | ​

​

As of June 30, 2024, contract receivables and contract receivables from related parties were $12,347, deferred revenue was $10,075, and total current liabilities were $22,949. As of December 31, 2023, contract receivables were $1,553, deferred revenue and deferred revenue from related parties was $829, and total current liabilities were $15,879.

​

Short-Term Liquidity Requirements

Short-term liquidity requirements include operating and capital expenses needed to further research and development programs and to further optimize pilot production lines and electrolyte manufacturing capabilities. We anticipate that our most significant capital expenditures for the remainder of 2024 will relate to enhancing the capabilities of our electrolyte production facility, including development of a design verification plan and report lab expected to be placed in service by the end of 2024. We expect to fund our short-term liquidity requirements through our cash on hand and other liquid assets.

Long-Term Liquidity Requirements

We believe that our cash on hand is sufficient to meet our operating cash needs and working capital and capital expenditure requirements for a period of at least the next 12 months and longer term until adequate cash flows from licensing activities and/or electrolyte sales can be generated. We also believe that we have adequate cash on hand for our stock repurchase program should we choose to execute additional share repurchases.

Additional liquidity sources may be required if there are material changes to our business conditions or other developments, including changes to our operating plan, development progress, negotiations with OEMs, cell manufacturers, or other suppliers, market adoption of EVs, supply chain challenges, competitive pressures, inflation, and regulatory developments. To the extent that our resources are insufficient to satisfy our cash requirements, we may need to seek additional equity or debt financing. We also may opportunistically seek to enhance our liquidity through equity or debt financing, if such financing becomes available on terms that we consider favorable. If financing is not available, or if the terms of financing are unfavorable, we may be forced to take actions to reduce our capital or operating expenditures, which may adversely affect our development, business, operating results, financial condition and prospects.

Stock Repurchase Program

On January 23, 2024, we announced that our Board approved a stock repurchase program authorizing the Company to purchase up to $50 million of our outstanding common stock. Under the stock repurchase program, we may purchase shares of our common stock from time to time until the repurchase program expires on December 31, 2025. The shares of common stock may be purchased on the open market, in unsolicited negotiated transactions, or in any manner that complies with the provisions of Rule 10b-18 of the Exchange Act. Management’s decision to repurchase shares of common stock will depend on a number of factors, such as the price of the common stock, economic and market conditions, and corporate and regulatory requirements. During the six months ended June 30, 2024, the Company repurchased 5,000,000 shares of common stock at an average price of $1.64 per share for an aggregate cost of approximately $8.36 million.

20

Table of Contents

Cash Flows

The following table summarizes our cash flows from operating, investing, and financing activities for the periods presented:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six Months Ended June 30, | ​
(in thousands) |  | 2024 |  | 2023 | ​
Net cash and cash equivalents used in operating activities | ​ | $ | (40,179) | ​ | $ | (36,304) | ​
Net cash and cash equivalents provided by investing activities | ​ | $ | 44,811 | ​ | $ | 14,486 | ​
Net cash and cash equivalents provided by (used in) financing activities | ​ | $ | (8,531) | ​ | $ | 134 | ​

​

Cash used in operating activities:

Cash used in operating activities increased from June 30, 2023 to 2024. The increase was largely attributable to operating losses, which were driven by a continued increase in research and development and selling, general and administrative costs.

Cash provided by investing activities:

Cash provided by investing activities increased from June 30, 2023 to 2024 primarily due to net effect of proceeds from the sales of marketable securities and decreased capital expenditures for property, plant and equipment.

Cash provided by (used in) financing activities:

Cash used in financing activities for the six months ended June 30, 2024 was predominantly related to the net effect of cash utilized for the stock repurchase program, partially offset by cash received from the exercise of stock options and proceeds from the sale of common stock under the ESPP. Cash provided by financing activities for the six months ended June 30, 2023 was primarily from the exercise of stock options and proceeds from the sale of common stock under the ESPP.

Off-Balance Sheet Arrangements

The Company is not a party to any off-balance sheet arrangements, as defined under SEC rules.

Critical Accounting Estimates

There were no significant and material changes in our critical accounting policies and use of estimates during the six months ended June 30, 2024 as compared to those disclosed in “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” in our 2023 Form 10-K.

Recent Accounting Pronouncements

See Note 2 of our unaudited financial statements included in this Report as well as Note 2 of our audited financial statements included in our 2023 Form 10-K for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company is a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired controls. As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2024.

21

Table of Contents

Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the three months ended June 30, 2024 covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, the Company become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

Item 1A. Risk Factors

Our business, prospects, reputation, results of operations, and financial condition, as well as the price of our common stock and warrants, can be affected by a number of factors, whether currently known or unknown, including those described in “Part I, Item 1A. Risk Factors” of our 2023 Form 10-K. When any one or more of these risks materialize from time to time, our business, reputation, results of operations, and financial condition, as well as the price of our common stock and warrants, can be materially and adversely affected. There have been no material changes to our risk factors since our 2023 Form 10-K.

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Share Repurchases

​

The following table summarizes our common stock repurchase program activity for the three months ended June 30, 2024:

​

| ​ |  | ​ | ​ |  | ​ |  | ​ | ​ | ​
| ​ |  | ​ | ​ |  | ​ |  | ​ | ​ | ​
Period | ​ | Total Number of Shares Purchased | ​ | Average Price Paid Per Share | ​ | Total Number of Shares Purchased as Part of Publicly Announced Program(1) | ​ | Approximate Dollar Value of Shares that May Yet Be Purchased under the Program(1)
April 1 - April 30, 2024 | ​ | 1,816,362 | ​ | $ | 1.85 | ​ | 1,816,362 | ​ | $ | 41,726,078
May 1 - May 31, 2024 | ​ | — | ​ | $ | — | ​ | — | ​ | $ | 41,726,078
June 1 - June 30, 2024 | ​ | — | ​ | $ | — | ​ | — | ​ | $ | 41,726,078
Total | ​ | 1,816,362 | ​ | $ | 1.85 | ​ | 1,816,362 | ​ | ​ | ​

​

(1)On January 23, 2024, we announced that our Board approved a stock repurchase program authorizing us to purchase up to $50 million of our outstanding common stock. Under the repurchase program, we may purchase shares of our common stock from time to time until the repurchase program expires on December 31, 2025. The shares of common stock may be purchased on the open market, in unsolicited negotiated transactions, or in any manner that complies with the provisions of Rule 10b-18 of the Exchange Act. Management’s decision to repurchase shares of common stock will depend on a number of factors, such as the price of our common stock, economic and market conditions, and corporate and regulatory requirements.

​

​

22

Table of Contents

Item 6. Exhibits

​

​ ​ | ​ |  | ​ |  | ​ |  | ​ |  | ​ |
​ | ​ | ​ | ​ | Incorporated by Reference
Exhibit Number | ​ | Description | ​ | Schedule Form | ​ | File Number | ​ | Exhibit/Annex | ​ | Filing Date
3.1 | ​ | Second Amended and Restated Certificate of Incorporation | ​ | 8-K | ​ | 001-40284 | ​ | 3.1 | ​ | December 13, 2021
3.2 | ​ | Amended and Restated Bylaws | ​ | 8-K | ​ | 001-40284 | ​ | 3.1 | ​ | November 21, 2022
10.1± | ​ | Amendment No. 5 to Joint Development Agreement, effective June 21, 2024, between Solid Power Operating, Inc. and BMW of North America, LLC | ​ | 8-K | ​ | 001-40284 | ​ | 10.1 | ​ | June 24, 2024
10.2# | ​ | Offer Letter with Linda Heller, dated June 14, 2024 | ​ | 8-K | ​ | 001-40284 | ​ | 10.1 | ​ | June 17, 2024
10.3*±# | ​ | Separation a nd Release Agreement with Kevin Paprzycki, dated July 11, 2024 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
31.1* | ​ | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
31.2* | ​ | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
32.1** | ​ | Section 1350 Certification | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
32.2** | ​ | Section 1350 Certification | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.INS* | ​ | XBRL Instance Document – the instance document does not appear in the Interactive Data file because its Inline XBRL tags are embedded within the Inline XBRL document. | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.SCH* | ​ | Inline XBRL Taxonomy Extension Schema Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.CAL* | ​ | Inline XBRL Taxonomy Extension Calculation Linkbase | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.DEF* | ​ | Inline XBRL Taxonomy Extension Definition Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.LAB* | ​ | Inline XBRL Taxonomy Extension Label Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.PRE* | ​ | Inline XBRL Taxonomy Extension Presentation Linkbase | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
104* | ​ | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

* Filed herewith.

** Furnished herewith.

± Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish an unredacted copy of the exhibit to the SEC upon request.

# Indicates a management or compensatory plan.

​

23

Table of Contents

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​ | ​
Date: August 7, 2024 | Solid Power, Inc.

​

​

​ | ​
​ | By: | /s/ John Van Scoter
​ | Name: | John Van Scoter
​ | Title: | President, Chief Executive Officer, and Director
​ | (Principal Executive Officer)

​

​

​ | ​
​ | By: | /s/ Linda Heller
​ | Name: | Linda Heller
​ | Title: | Chief Financial Officer and Treasurer
​ | (Principal Financial and Accounting Officer)

​

​

​

​

24